Monitoring of IN VITRO deamination of gliadin peptic fragments by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development

Abstract

The sequence of one of the macrophage-stimulatory peptide was determined by mass spectrometry.

Keywords

• mass spectrometry
• sequencing
• gliadin
• celiac disease
• innate immunity